Section Arrow
Quote
BCAX.NASDAQ
- Bicara Therapeutics Inc.
Quotes are at least 15-min delayed:2025/07/17 03:17 EDT
Regular Hours
Last
 10.79
+0.56 (+5.47%)
Day High 
10.85 
Prev. Close
10.23 
1-M High
11.06 
Volume 
331.36K 
Bid
--
Ask
--
Day Low
10.31 
Open
10.34 
1-M Low
8.48 
Market Cap 
557.91M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 9.57 
20-SMA 9.43 
50-SMA 11.17 
52-W High 28.09 
52-W Low 7.8 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.69/-2.59
Enterprise Value
558.04M
Balance Sheet
Book Value Per Share
8.42
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
APMAptorum Group Limited1.94+0.9702+100.04%2.77PE
TNFATNF Pharmaceuticals Inc.0.109+0.0028+2.64%-- 
NCNANuCana plc0.0502--0.000%-- 
BRNSBarinthus Biotherapeutics plc1.42+0.4+39.22%-- 
WINTWindtree Therapeutics Inc.0.9+0.0714+8.62%0.84PE
Quotes are at least 15-min delayed：2025/07/17 03:17 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.